Skip to main content
FinSpry Logo
FinSpry
SMMT logo
SMMT
(NASDAQ)
Summit Therapeutics Inc.
$19.38-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Summit Therapeutics (SMMT) Stock Price & Financial Analysis

Summit Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$18.40 - $19.85
52-Week High$36.91
52-Week Low$13.83
Open$18.40
Volume3.08M
Average Volume (3M)3.08M
Market Cap14.49B
Shares Outstanding747.70M
Price to Book (P/B)21.47
EV/EBITDA-17.40
50-Day MA$15.85
200-Day MA$19.84
52-Week Change0.64%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Summit Therapeutics

What is the current stock price for SMMT?

As of the latest trading session, SMMT stock trades at $19.38. The 52-week range is $13.83–$36.91, with a day range of $18.40–$19.85.

What is the P/E ratio for SMMT?

The P/E ratio (Price-to-Earnings) for SMMT is shown in the Key Statistics section. This valuation metric helps compare Summit Therapeutics Inc. to industry peers.

Does SMMT pay dividends?

Summit Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SMMT?

Based on 3 analysts, the consensus for SMMT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of SMMT?

Summit Therapeutics's market capitalization is $14.49B, classifying it as a large-cap company. Summit Therapeutics operates in the Healthcare sector within the Biotechnology industry.